Ms. Denise Faltischek reports

TILRAY EXPANDS MEDICAL CANNABIS PORTFOLIO IN GERMANY

Tilray Medical, a division of Tilray Brands Inc. and a global leader in medical cannabis, empowering the therapeutic alliance between patients and health care practitioners to make informed individualized health decisions, has expanded its industry-leading medical cannabis extract portfolio in Germany. Tilray's new medical cannabis offerings in Germany include the introduction of an additional product size for its top-selling medical cannabis extract, along with a new formulation aimed at addressing the diverse needs of patients and health care providers. Recognizing the increasing demand for balanced medical cannabis extracts, which are among the top-prescribed medical cannabis extracts in Germany, Tilray Medical introduces the following:

• Tilray THC50 CBD50 (25 millilitres) -- a high-potency 1:1 medical cannabis extract designed for patients requiring higher cannabinoid content, offering an option for those who need stronger therapeutic effects while maintaining the same balanced THC:CBD (tetrahydrocannabinol to cannabidiol) ratio that has become in demand in Germany;
• Tilray THC10 CBD10 (10 millilitres) -- a new trial size version of Tilray Medical's top-selling medical cannabis extract, responding to demand from patients and physicians for smaller formats that allow for more accessible initial dosing and treatment exploration.

Denise Faltischek, chief strategy officer and head of international, said: "Our unwavering focus on innovation and education, together with our dedication to patient care, drives everything we do. Because of this, physicians and patients around the world trust the efficacy and safety of our products, which is evidenced by our position as the leading provider of medical cannabis extracts in Germany. In consultation with health care providers, we continuously evaluate our portfolio and are developing new innovations, including these new product launches to meet diverse patient needs. "

Tilray Medical's medical cannabis products are available with a physician's prescription at pharmacies throughout Germany:

• Tilray THC10 CBD10 -- 25 millilitres and 10 millilitres;
• Tilray THC50 CBD50 -- 25 millilitres;
• Tilray THC25 CBD25 -- 25 millilitres;
• Tilray THC25;
• Tilray THC5 CBD20;
• Tilray THC20 CBD6.

About Tilray Medical

Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray Medical, Broken Coast, Redecan, Good Supply and Navcora. Tilray Medical grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified (good manufacturing practices) cannabis production facilities in Portugal and Germany. Today, Tilray Medical is a leading supplier of medical cannabis with a portfolio of brands and products designed to meet the needs of its patients worldwide.

About Tilray Brands Inc.

Tilray Brands is a leading global lifestyle and consumer packaged goods company (with operations in Canada, the United States, Europe, Australia, New Zealand and Latin America) that is leading as a transformative force at the nexus of cannabis, beverage, wellness and entertainment, elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages.

We seek Safe Harbor.